ATE314068T1 - Behandlung von seborrhoischer dermatitis - Google Patents

Behandlung von seborrhoischer dermatitis

Info

Publication number
ATE314068T1
ATE314068T1 AT01984091T AT01984091T ATE314068T1 AT E314068 T1 ATE314068 T1 AT E314068T1 AT 01984091 T AT01984091 T AT 01984091T AT 01984091 T AT01984091 T AT 01984091T AT E314068 T1 ATE314068 T1 AT E314068T1
Authority
AT
Austria
Prior art keywords
lotion
cream
treatment
seborrhoic dermatitis
ivermectin
Prior art date
Application number
AT01984091T
Other languages
German (de)
English (en)
Inventor
L Dean Parks
Original Assignee
L Dean Parks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L Dean Parks filed Critical L Dean Parks
Application granted granted Critical
Publication of ATE314068T1 publication Critical patent/ATE314068T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01984091T 2000-06-29 2001-06-27 Behandlung von seborrhoischer dermatitis ATE314068T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/605,747 US6319945B1 (en) 2000-06-29 2000-06-29 Method of treatment of seborrheic dermatitis
PCT/US2001/041159 WO2002002056A2 (en) 2000-06-29 2001-06-27 Method of treatment of seborrheic dermatitis

Publications (1)

Publication Number Publication Date
ATE314068T1 true ATE314068T1 (de) 2006-01-15

Family

ID=24425042

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01984091T ATE314068T1 (de) 2000-06-29 2001-06-27 Behandlung von seborrhoischer dermatitis

Country Status (10)

Country Link
US (2) US6319945B1 (enExample)
EP (1) EP1294375B1 (enExample)
JP (1) JP3802485B2 (enExample)
CN (1) CN1171588C (enExample)
AT (1) ATE314068T1 (enExample)
AU (1) AU2002216748A1 (enExample)
CA (1) CA2384448C (enExample)
DE (1) DE60116302T2 (enExample)
ES (1) ES2252312T3 (enExample)
WO (1) WO2002002056A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
AU2003247735B2 (en) 2002-06-26 2010-03-11 Avery Dennison Corporation Oriented films comprising polypropylene / olefin elastomer blends
BRPI0410503B8 (pt) * 2003-04-24 2021-05-25 Galderma Sa composição tópica e uso da composição
FR2854074B1 (fr) * 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
CN103121320B (zh) 2006-06-14 2015-06-24 艾利丹尼森公司 可顺应和可冲切的轴向定向的标签原料和标签及制备方法
BRPI0713492A2 (pt) 2006-06-20 2012-01-24 Avery Dennison Corp filme polimérico de multi-camadas para rotulagem de adesivos de derretimento a quente e etiqueta e rótulo dos mesmos
CA2666365C (en) * 2006-10-12 2016-08-09 Topaz Pharmaceuticals Llc Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US8901163B2 (en) 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
WO2012054331A1 (en) 2010-10-20 2012-04-26 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
EP2629772B1 (en) 2010-10-20 2016-05-18 Galderma S.A. Ivermectin for use in the treatment of hemorrhoids
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233118B2 (en) 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
AU2015270854B2 (en) 2014-06-02 2018-08-02 Avery Dennison Corporation Films with enhanced scuff resistance, clarity, and conformability
CN110604741A (zh) * 2018-06-15 2019-12-24 瑞恩生化科技有限公司 抑制皮肤细胞增生的组合物及其应用
EP4062907A1 (fr) 2021-03-23 2022-09-28 Substipharm Formulation par voie orale d'ivermectine et utilisations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5877295A (en) * 1992-09-30 1999-03-02 The Center For Blood Research Antibodies which bind a subpopulation of Mac-1 (CD11b/CD18) molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen
DE4328689A1 (de) * 1993-08-26 1995-03-02 Beiersdorf Ag Verfahren zur Detektion und Zählung von Mikroorganismen
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
WO1997044034A1 (en) * 1996-05-20 1997-11-27 Otsuka Pharmaceutical Co., Ltd. Remedy for rosacea
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
KR100315465B1 (ko) * 1998-11-23 2002-02-19 성재갑 수용성고분자와알코올을포함하는주사제용동물구충제조성물

Also Published As

Publication number Publication date
CA2384448C (en) 2008-09-16
EP1294375A2 (en) 2003-03-26
US6319945B1 (en) 2001-11-20
AU2002216748A1 (en) 2002-01-14
DE60116302T2 (de) 2006-08-10
JP2004501939A (ja) 2004-01-22
WO2002002056A3 (en) 2002-03-28
WO2002002056A2 (en) 2002-01-10
CN1171588C (zh) 2004-10-20
ES2252312T3 (es) 2006-05-16
EP1294375A4 (en) 2004-06-09
DE60116302D1 (de) 2006-02-02
CA2384448A1 (en) 2002-01-10
JP3802485B2 (ja) 2006-07-26
US20020019354A1 (en) 2002-02-14
EP1294375B1 (en) 2005-12-28
CN1383379A (zh) 2002-12-04
US6433006B2 (en) 2002-08-13

Similar Documents

Publication Publication Date Title
DE60116302D1 (de) Behandlung von seborrhoischer dermatitis
ATE184794T1 (de) Zusammensetzungen, die troxerutin als komplex mit phosphatidylcholin enthalten, zur topischen behandlung von erektionsimpotenz
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
NZ318282A (en) Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
SE8804570D0 (sv) New ciclosporin crystal form process for its produktion pharmaceutical compositions containing it and its use
DE69802113D1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
SE9603725D0 (sv) New teatment
NO962655L (no) Deutrerte virkestoffer i transdermal applikasjon
AU1870097A (en) Use of a medicament and use of mixture of substances to produce a medicament
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
KR880004810A (ko) 소화성 궤양 치료제
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
ZA969351B (en) Organic compositions
ATE271896T1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
DE69430867D1 (de) Verwendung von terbinafin zur behandlung von pneumocystosis
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
NO962503L (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
KR900017599A (ko) 종양 치료용 약학 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties